Citation: I. Edhemovic et al., 2ND PRIMARY CANCERS FOLLOWING THYROID-CANCER IN SLOVENIA - A POPULATION-BASED COHORT STUDY, European journal of cancer, 34(11), 1998, pp. 1813-1814
Authors:
SENTJURC M
ZOREC M
CEMAZAR M
AUERSPERG M
SERSA G
Citation: M. Sentjurc et al., EFFECT OF VINBLASTINE ON CELL-MEMBRANE FLUIDITY IN VINBLASTINE-SENSITIVE AND VINBLASTINE-RESISTANT HELA-CELLS, Cancer letters, 130(1-2), 1998, pp. 183-190
Citation: M. Hocevar et al., THE DYNAMICS OF SERUM THYROGLOBULIN ELIMINATION FROM THE BODY AFTER THYROID-SURGERY, European journal of surgical oncology, 23(3), 1997, pp. 208-210
Citation: M. Cemazar et al., ANTITUMOR EFFECTIVENESS OF BOLUS VERSUS SPLIT-DOSE VINBLASTINE TREATMENT IN EAT TUMORS IN MICE, Anticancer research, 17(6D), 1997, pp. 4553-4556
Authors:
VOLAVSEK M
USKRASOVEC M
AUERSPERG M
HOCEVAR M
GOLOUH R
Citation: M. Volavsek et al., MARGINAL VACUOLES IN FINE-NEEDLE ASPIRATES OF FOLLICULAR THYROID-CARCINOMA, Diagnostic cytopathology, 15(2), 1996, pp. 93-97
Authors:
AUERSPERG M
USKRASOVEC M
POGACNIK A
HOCEVAR M
PALCIC B
GARNER D
Citation: M. Auersperg et al., VINBLASTINE (VLB) IN DIFFERENTIATED THYROID-CARCINOMA (DTC) EFFECT MONITORED BY DNA MEASUREMENTS, European journal of cancer, 31A, 1995, pp. 433-433
Citation: M. Hocevar et M. Auersperg, USE OF SERUM THYROGLOBULIN FOR MONITORING THE EFFECT OF CHEMOTHERAPY AND IRRADIATION IN DIFFERENTIATED THYROID-CANCER, European journal of cancer, 31A, 1995, pp. 1266-1266
Authors:
JEZERSEK B
NOVAKOVIC S
SERSA G
AUERSPERG M
FLEISCHMANN WR
Citation: B. Jezersek et al., INTERACTIONS OF INTERFERON AND VINBLASTINE ON EXPERIMENTAL TUMOR-MODEL MELANOMA-B-16 IN-VITRO, Anti-cancer drugs, 5(1), 1994, pp. 53-56
Authors:
SERSA G
CEMAZAR M
SENTJURC M
USKRASOVEC M
KALEBIC S
DRASLAR K
AUERSPERG M
Citation: G. Sersa et al., EFFECTS OF VINBLASTINE ON CELL-MEMBRANE FLUIDITY AND THE GROWTH OF SA-1 TUMOR IN MICE, Cancer letters, 79(1), 1994, pp. 53-60